Ensayo clínico

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT: NCT06388707 · RECRUITING

ID NCTNCT06388707

EstadoRECRUITING

Fecha de inicio2024-09-13

Finalización2027-10-31

SponsorNaviFUS Corporation (INDUSTRY)

First posted2024-04-29

Last updated2026-09-15

Resumen breve

This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.